Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Touyun Biotech Group Ltd. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -14.22% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Jun 25
- RAW MATERIAL COST(Y) Grown by 20.92% (YoY)
- CASH AND EQV(HY) Lowest at HKD 11.53 MM
- NET SALES(Q) Lowest at HKD 31.52 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -4.60%, its profits have risen by 43.6%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -4.60% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Packaging)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Touyun Biotech Group Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Touyun Biotech Group Ltd.
-100.0%
-0.08
268.69%
Hang Seng Hong Kong
8.25%
0.41
19.93%
Quality key factors
Factor
Value
Sales Growth (5y)
-14.22%
EBIT Growth (5y)
1.11%
EBIT to Interest (avg)
-4.51
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-3.69
Sales to Capital Employed (avg)
0.43
Tax Ratio
0.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-2.77
EV to EBIT
-11.26
EV to EBITDA
-29.45
EV to Capital Employed
2.40
EV to Sales
3.36
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-21.29%
ROE (Latest)
Negative BV
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Movement
2What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 2.29 times
EPS(Q)
Highest at HKD 0
-7What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 20.92% (YoY
CASH AND EQV(HY)
Lowest at HKD 11.53 MM
NET SALES(Q)
Lowest at HKD 31.52 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -91.16 %
NET PROFIT(Q)
Lowest at HKD -55.56 MM
Here's what is working for Touyun Biotech Group Ltd.
EPS
Highest at HKD 0
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Debtors Turnover Ratio
Highest at 2.29 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Touyun Biotech Group Ltd.
Net Sales
At HKD 31.52 MM has Fallen at -57.56%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (HKD MM)
Net Sales
Lowest at HKD 31.52 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Operating Profit Margin
Lowest at -91.16 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Net Profit
Lowest at HKD -55.56 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
Cash and Eqv
Lowest at HKD 11.53 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 20.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






